Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Stone

Showing results (101-110 of 420) with videos related to

Pageof 42
Sort By:
Leukemia Research|May 7, 2013
Predictive factors for all-trans retinoic acid-related differentiation syndrome in patients with acute promyelocytic leukemiaHoury Leblebjian, Daniel J DeAngelo, J Andrew Skirvin, et al.
JAMA Oncology|March 2, 2018
Prevalence of Cognitive Impairment and Association With Survival Among Older Patients With Hematologic CancersTammy T Hshieh, Wooram F Jung, Laura J Grande, et al.
Cell|October 16, 2012
Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AMLThanh-Trang Vo, Jeremy Ryan, Ruben Carrasco, et al.
Oncotarget|October 6, 2017
Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogrammingHaymanti Bhanot, Ellen L Weisberg, Mamatha M Reddy, et al.
Leukemia Research|February 14, 2014
A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemiaDaniel J Deangelo, Donna Neuberg, Philip C Amrein, et al.
Leukemia Research|September 29, 2015
Identification of ILK as a novel therapeutic target for acute and chronic myeloid leukemiaPilar de la Puente, Ellen Weisberg, Barbara Muz, et al.
Leukemia Research|June 11, 2013
Geriatric assessment in older patients with acute myeloid leukemia: a retrospective study of associated treatment and outcomesAlexander E Sherman, Gabriela Motyckova, K Rebecca Fega, et al.
American Journal of Hematology|November 4, 2015
Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trialsJorge J Castillo, Flora Mulkey, Susan Geyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosisAnimesh Pardanani, Jason R Gotlib, Catriona Jamieson, et al.
Leukemia & Lymphoma|May 3, 2008
Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia--Cancer and leukemia group B study 10107Meir Wetzler, Kathleen A Donohue, Olatoyosi M Odenike, et al.
Pageof 42

Showing results (101-110 of 420) with videos related to

Sort By:
Pageof 42
Leukemia Research|May 7, 2013
Predictive factors for all-trans retinoic acid-related differentiation syndrome in patients with acute promyelocytic leukemiaHoury Leblebjian, Daniel J DeAngelo, J Andrew Skirvin, et al.
JAMA Oncology|March 2, 2018
Prevalence of Cognitive Impairment and Association With Survival Among Older Patients With Hematologic CancersTammy T Hshieh, Wooram F Jung, Laura J Grande, et al.
Cell|October 16, 2012
Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AMLThanh-Trang Vo, Jeremy Ryan, Ruben Carrasco, et al.
Oncotarget|October 6, 2017
Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogrammingHaymanti Bhanot, Ellen L Weisberg, Mamatha M Reddy, et al.
Leukemia Research|February 14, 2014
A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemiaDaniel J Deangelo, Donna Neuberg, Philip C Amrein, et al.
Leukemia Research|September 29, 2015
Identification of ILK as a novel therapeutic target for acute and chronic myeloid leukemiaPilar de la Puente, Ellen Weisberg, Barbara Muz, et al.
Leukemia Research|June 11, 2013
Geriatric assessment in older patients with acute myeloid leukemia: a retrospective study of associated treatment and outcomesAlexander E Sherman, Gabriela Motyckova, K Rebecca Fega, et al.
American Journal of Hematology|November 4, 2015
Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trialsJorge J Castillo, Flora Mulkey, Susan Geyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosisAnimesh Pardanani, Jason R Gotlib, Catriona Jamieson, et al.
Leukemia & Lymphoma|May 3, 2008
Feasibility of administering oblimersen (G3139; Genasense) with imatinib mesylate in patients with imatinib resistant chronic myeloid leukemia--Cancer and leukemia group B study 10107Meir Wetzler, Kathleen A Donohue, Olatoyosi M Odenike, et al.
Pageof 42